NeuroPhage is a series a startup based in Israel. 1 investor tracked on Brouky Intelligence. Status: acquired. Data sourced from Brouky Intelligence.
About
NeuroPhage is a biotechnology company focused on developing novel therapies for neurodegenerative diseases using bacteriophage technology.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky